Abstract:The MBD4 enzyme initiates the process of DNA demethylation by the excision of modified DNA bases, resulting in the formation of apurinic/apyrimidinic sites. MBD4 contains a methyl-CpG-binding domain which provides the localization of the enzyme at the CpG sites, and a DNA glycosylase domain that is responsible for the catalytic activity. The aim of this work was to clarify the mechanisms of specific site recognition and formation of catalytically active complexes between model DNA substrates and the catalytic N-glycosylase domain MBD4cat. The conformational changes in MBD4cat and DNA substrates during their interaction were recorded in real time by stopped-flow detection of the fluorescence of tryptophan residues in the enzyme and fluorophores in DNA. A kinetic scheme of MBD4cat interaction with DNA was proposed, and the rate constants for the formation and decomposition of transient reaction intermediates were calculated. Using DNA substrates of different lengths, the formation of the catalytically active complex was shown to follow the primary DNA binding step which is responsible for the search and recognition of the modified base. The results reveal that in the primary complex of MBD4cat with DNA containing modified nucleotides, local melting and bending of the DNA strand occur. On the next step, when the catalytically competent conformation of the enzyme-substrate complex is formed, the modified nucleotide is everted from the double DNA helix into the active center and the void in the helix is filled by the enzymes amino acids.

Research progress of the structure and function of methylated CpG-binding protein MBD4/MED1

Dissecting the behavior and function of MBD3 in DNA methylation homeostasis by single-molecule spectroscopy and microscopy

Mechanistic model for epigenetic maintenance by methyl-CpG-binding domain proteins

Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer.

DNA methylation, its mediators and genome integrity.

N 4-Cytosine DNA Methylation is Involved in the Maintenance of Genomic Stability in Deinococcus Radiodurans.

Search for Modified DNA Sites with the Human Methyl-CpG-Binding Enzyme MBD4

MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1

Circulating Methylated DNA As Biomarkers for Cancer Detection

Structural and functional insights into the epigenetic regulator MRG15

Impact of Histone H4 Lysine 20 Methylation on 53BP1 Responses to Chromosomal Double Strand Breaks

A Nucleosome Bridging Mechanism for Activation of a Maintenance DNA Methyltransferase.

MBD3L2 promotes Tet2 enzymatic activity for mediating 5-methylcytosine oxidation.

DNA-binding proteins from MBD through ZF to BEN: recognition of cytosine methylation status by one arginine with two conformations

Methyl-CpG-binding Domain Protein 3-Like 2 (MBD3L2) Promotes Tet2 Enzymatic Activity for Mediating 5mc Oxidation

MDM4 was associated with poor prognosis and tumor-immune infiltration of cancers

High Resolution Detection and Analysis of CpG Dinucleotides Methylation Using MBD-Seq Technology

MDM2 Promotes Genome Instability by Ubiquitinating the Transcription Factor HBP1

Acetylation of MLH1 by CBP increases cellular DNA mismatch repair activity

Silencing of MBD 1 Reverses Pancreatic Cancer Therapy Resistance Through Inhibition of DNA Damage Repair

The Role of DNA Repair Gene MGMT on Cancer Occurrence and Prognosis